Sign In

Michael Milone

Associate Professor at University of Pennsylvania School of Medicine

Michael Milone is a co-founder and co-chair of the Scientific Advisory Board at Verismo Therapeutics, a company pioneering CAR T-cell therapy for the treatment of solid tumors.13 He is also an Associate Professor of Pathology and Laboratory Medicine at the University of Pennsylvania.6

Dr. Milone's background is impressive:

Education and Expertise

  • He holds an M.D. in Medicine & Immunology and a Ph.D. in Immunology.4
  • He has over 25 years of experience in cell and gene therapy as a physician-scientist.5

Contributions to CAR T-cell Therapy

Dr. Milone is one of the inventors of Kymriah™, the first FDA-approved CAR T-cell therapy.1 Building on this groundbreaking work, he co-founded Verismo Therapeutics to develop next-generation CAR T-cell therapies, specifically:

  • The KIR-CAR platform, which aims to overcome limitations of first-generation CAR T therapies.1
  • SynKIR™, a novel chimeric antigen receptor design based on killer immunoglobulin-like receptors (KIRs).3

Recent Developments

In 2024, Verismo Therapeutics received FDA clearance for a Phase I trial of its CAR-T therapy, SynKIR-310, targeting relapsed or refractory B-cell non-Hodgkin lymphomas.2 This represents a significant milestone in Dr. Milone's ongoing work to advance cell therapies for cancer treatment.

Dr. Milone's LinkedIn username is michael-milone-5a251736, as provided in the query.

Highlights

May 10 · linkedin

A dose of reality from a real vaccine expert...

Related Questions

What is Michael Milone's background in cell and gene therapy?
How did Michael Milone contribute to the development of Kymriah?
What is the significance of the KIR-CAR platform in Verismo's therapies?
What are the main challenges Verismo Therapeutics is addressing with their CAR-T technology?
How does Verismo's SynKIR-310 differ from traditional CAR-T therapies?
Michael Milone
Michael Milone, photo 1
Michael Milone, photo 2
Add to my network

Location

Greater Philadelphia